NASDAQ:CBAY
Delisted

Cymabay Therapeutics Stock Forecast

etoro logo Buy CBAY
*Your capital is at risk
$32.48
+0 (+0%)
At Close: Apr 11, 2024
PDF

Cymabay Therapeutics Inc stock price down 0% on Thursday
(Updated on Apr 11, 2024)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jan 26, 2024 Gain 41.03%

No changes to the price of Cymabay Therapeutics Inc stock on the last trading day (Thursday, 11th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $32.48 to a day high of $32.48. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $32.20 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 42.15% during the next 3 months and, with a 90% probability hold a price between $45.77 and $53.73 at the end of this 3-month period.

CBAY Signals & Forecast

The Cymabay Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $32.48 and $32.40. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 10, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation

Support, Risk & Stop-loss for Cymabay Therapeutics Inc stock

Cymabay Therapeutics Inc finds support from accumulated volume at $32.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $31.18 (-4.00%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CBAY) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect Cymabay Therapeutics Inc to open at $32.48, and during the day (based on 14 day Average True Range), to move between $32.43 and $32.53, which gives a possible trading interval of +/-$0.0904 (+/-0.28%) up or down from last closing price. If Cymabay Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 0.28% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $32.21, some $0.270 (0.83%) from the current price of $32.48, our system finds the risk reward attractive.

Is Cymabay Therapeutics Inc stock A Buy?

Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on April 12, 2024 - $32.48 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CBAY Performance

Trading levels for CBAY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 32.48 -
R2 32.48 -
R1 32.48 -
Price 32.48
S1 32.48 -
S2 32.48 -
S3 32.48 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 32.48
S1 32.21 -0.83%
S2 32.18 -0.92%
S3 32.12 -1.11%

FAQ

What is the symbol for Cymabay Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Cymabay Therapeutics Inc is CBAY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cymabay Therapeutics Inc Stock?
Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Cymabay Therapeutics Inc Stock?
Cymabay Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cymabay Therapeutics Inc Stock.

What's the current price of Cymabay Therapeutics Inc Stock?
As of the end of day on the Apr 11, 2024, the price of an Cymabay Therapeutics Inc (CBAY) share was $32.48.

What is the 52-week high and low for Cymabay Therapeutics Inc Stock?
The 52-week high for Cymabay Therapeutics Inc Stock is $32.50 and the 52-week low is $7.26.

What is the market capitalization of Cymabay Therapeutics Inc Stock?
As of the Apr 11, 2024, the market capitalization of Cymabay Therapeutics Inc is 3.728B.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE